Literature DB >> 7524881

Parotid saliva composition during and after irradiation of head and neck cancer.

U Funegård1, L Franzén, T Ericson, R Henriksson.   

Abstract

Parotid saliva composition was studied before, during and up to 18 months after the irradiation period in 16 cancer patients treated for malignancies in the head and neck region. Stimulated parotid saliva was collected prior to radiotherapy and, when possible, weekly during treatment. New samples were taken 2, 4, 6, 12 and 18 months after the end of radiotherapy. Nine of the 16 patients were treated with bilateral irradiation fields and 7 patients with unilateral irradiation fields, with a total dose not exceeding 52 Gy. During the entire irradiation period the fraction of glands producing measurable volumes of saliva decreased to 40%. In the postirradiation period the number of active glands gradually increased and saliva secretion rate returned to an average of 72% of the initial value 18 months after the end of irradiation. The concentrations of the measured variables increased already during the first week of radiotherapy and at the end of the treatment period the concentrations for total protein, salivary peroxidase, hexosamine and salivary IgA were significantly increased. The concentrations for total protein, salivary peroxidase and salivary IgA were still increased 6 months after the end of irradiation. At the 18-months observation all concentrations had returned to normal, as evaluated in a paired t-test. The majority of glands irradiated with 40-52 Gy recovered not only in secretion rates but also with respect to the components studied in this investigation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7524881     DOI: 10.1016/0964-1955(94)90002-7

Source DB:  PubMed          Journal:  Eur J Cancer B Oral Oncol        ISSN: 0964-1955


  7 in total

1.  Does irradiation affect the protein composition of saliva?

Authors:  M Hannig; E Dounis; T Henning; N Apitz; L Stösser
Journal:  Clin Oral Investig       Date:  2006-02-01       Impact factor: 3.573

2.  Analysis of factors influencing the development of xerostomia during intensity-modulated radiotherapy.

Authors:  Ken Randall; Jason Stevens; Juan Fernando Yepes; Marcus E Randall; Mahesh Kudrimoti; Jonathan Feddock; Jing Xi; Richard J Kryscio; Craig S Miller
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol       Date:  2013-03-22

3.  Design of a randomized controlled double-blind crossover clinical trial to assess the effects of saliva substitutes on bovine enamel and dentin in situ.

Authors:  Peter Tschoppe; Olivia Wolf; Michael Eichhorn; Peter Martus; Andrej M Kielbassa
Journal:  BMC Oral Health       Date:  2011-04-09       Impact factor: 2.757

4.  Quantification of very late xerostomia in head and neck cancer patients after irradiation.

Authors:  Grace C Blitzer; Nicole M Rogus-Pulia; Cristina Paz; Kwangok P Nickel; Vanessa L Cannaday; Cynthia A Kelm-Nelson; Sailendharan Sudakaran; Richard J Chappell; Tiffany Glazer; Randall J Kimple
Journal:  Laryngoscope Investig Otolaryngol       Date:  2022-07-12

5.  The effect of parotid gland-sparing intensity-modulated radiotherapy on salivary composition, flow rate and xerostomia measures.

Authors:  T M Richards; T Hurley; L Grove; K J Harrington; G H Carpenter; G B Proctor; C M Nutting
Journal:  Oral Dis       Date:  2017-06-05       Impact factor: 3.511

6.  Proteins and peptides in parotid saliva of irradiated patients compared to that of healthy controls using SELDI-TOF-MS.

Authors:  Alexa M G A Laheij; Coen N Rasch; Bernd W Brandt; Johannes J de Soet; Raymond G Schipper; Arnoud Loof; Erika Silletti; Cor van Loveren
Journal:  BMC Res Notes       Date:  2015-11-03

Review 7.  Radiation-Induced Salivary Gland Dysfunction: Mechanisms, Therapeutics and Future Directions.

Authors:  Kimberly J Jasmer; Kristy E Gilman; Kevin Muñoz Forti; Gary A Weisman; Kirsten H Limesand
Journal:  J Clin Med       Date:  2020-12-18       Impact factor: 4.964

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.